30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Traws Pharma Inc (TRAW)

Track

Over the last 90 days, Traws Pharma Inc. has seen one significant insider transaction: a large buy of $998,207.43 by ORBIMED ADVISORS LLC. This contrasts with earlier, smaller proposed sales by officers and planned purchases by an SVP in 2022. The company's stock has declined 11.4% in the past 90 days.
Stock chart
Ticker: TRAW Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ORBIMED ADVISORS LLC
1 purchase — total 998,207 USD
Buy 16 Apr 2026
Value US$1,495,249.66 | Price 439.47 | Shares 69,557
Proposed sale 14 Mar 2024
Value US$724,304.31 | Price 89.65 | Shares 54,868
Proposed sale 14 Mar 2024
Value US$7,859.54 | Price 0.90 | Shares 8,727
Proposed sale 8 Feb 2024
Value US$6,172.96 | Price 0.67 | Shares 9,212
Planned buy 28 Jan 2022
Value US$2,505.00 | Price 1.67 | Shares 1,500
Planned buy 21 Jan 2022
Value US$3,030.00 | Price 2.02 | Shares 1,500
Planned buy 14 Jan 2022
Value US$3,300.00 | Price 2.20 | Shares 1,500
Planned buy 7 Jan 2022
Value US$3,585.00 | Price 2.39 | Shares 1,500
Buy 19 Nov 2021
Value US$3,160.00 | Price 3.16 | Shares 1,000
Buy 28 Sep 2021
Value US$10,000.20 | Price 4.20 | Shares 2,381
Buy 28 Sep 2021
Value US$10,000.20 | Price 4.20 | Shares 2,381
Buy 28 Sep 2021
Value US$24,998.40 | Price 4.20 | Shares 5,952
Buy 28 Sep 2021
Value US$10,000.20 | Price 4.20 | Shares 2,381
Buy 16 Feb 2021
Value US$25,000.00 | Price 1.00 | Shares 25,000
Buy 16 Feb 2021
Value US$15,000.00 | Price 1.00 | Shares 15,000
Buy 16 Feb 2021
Value US$20,000.00 | Price 1.00 | Shares 20,000
Buy 16 Feb 2021
Value US$12,000.00 | Price 1.00 | Shares 12,000
Buy 16 Feb 2021
Value US$13,000.00 | Price 1.00 | Shares 13,000
Buy 11 Dec 2020
Value US$9,600.00 | Price 0.32 | Shares 30,000
Buy 27 Nov 2020
Value US$1,199.64 | Price 0.26 | Shares 4,614
Buy 25 Nov 2020
Value US$9,999.78 | Price 0.27 | Shares 37,735
Buy 25 Nov 2020
Value US$4,356.30 | Price 0.26 | Shares 16,755
Buy 25 Nov 2020
Value US$5,120.00 | Price 0.26 | Shares 20,000
Buy 25 Nov 2020
Value US$10,360.00 | Price 0.26 | Shares 40,000
Buy 24 Nov 2020
Value US$10,003.69 | Price 0.26 | Shares 38,774
Sale 27 Aug 2020
Value US$510.08 | Price 0.27 | Shares 1,876
Sale 27 Aug 2020
Value US$49,619.57 | Price 0.27 | Shares 182,492
Sale 27 Aug 2020
Value US$143,948.24 | Price 0.27 | Shares 527,863
Buy 19 May 2020
Value US$3,626.00 | Price 0.36 | Shares 10,000
Buy 19 May 2020
Value US$9,857.04 | Price 0.37 | Shares 26,800
Buy 19 May 2020
Value US$7,560.00 | Price 0.36 | Shares 21,000
Buy 19 May 2020
Value US$5,550.00 | Price 0.37 | Shares 15,000
Buy 25 Nov 2019
Value US$50,000.00 | Price 0.20 | Shares 250,000
Buy 25 Nov 2019
Value US$15,000.00 | Price 0.20 | Shares 75,000
Buy 25 Nov 2019
Value US$17,500.00 | Price 0.20 | Shares 87,500
Buy 25 Nov 2019
Value US$30,000.00 | Price 0.20 | Shares 150,000
Buy 25 Nov 2019
Value US$29,800.00 | Price 0.20 | Shares 149,000
Buy 25 Nov 2019
Value US$100,000.00 | Price 0.20 | Shares 500,000
Buy 25 Sep 2019
Value US$11,616.00 | Price 1.60 | Shares 7,260
Sale 24 Sep 2019
Value US$19,873.00 | Price 1.19 | Shares 16,700
Sale 23 Sep 2019
Value US$0.00 | Price 0.00 | Shares 0
Sale 23 Sep 2019
Value US$13,016.23 | Price 1.27 | Shares 10,249
Sale 23 Sep 2019
Value US$45,967.80 | Price 1.23 | Shares 37,242
Sale 20 Sep 2019
Value US$121,429.86 | Price 1.62 | Shares 75,119
Sale 18 Sep 2019
Value US$3,375.97 | Price 2.20 | Shares 1,533
Sale 18 Sep 2019
Value US$218,184.00 | Price 1.82 | Shares 120,000
Sale 18 Sep 2019
Value US$377,447.76 | Price 2.18 | Shares 173,332
Sale 18 Sep 2019
Value US$173,138.82 | Price 1.86 | Shares 93,286
Sale 18 Sep 2019
Value US$258,537.74 | Price 2.18 | Shares 118,726
Sale 18 Sep 2019
Value US$105,014.50 | Price 2.10 | Shares 49,995
Sale 11 Sep 2019
Value US$3,432.49 | Price 2.75 | Shares 1,247
Sale 9 Sep 2019
Value US$1,106.00 | Price 2.77 | Shares 400
Sale 6 Sep 2019
Value US$13,954.24 | Price 2.78 | Shares 5,015
Sale 5 Sep 2019
Value US$1,100.00 | Price 2.75 | Shares 400
Sale 10 Jul 2019
Value US$7,696.79 | Price 2.81 | Shares 2,742
Sale 9 Jul 2019
Value US$23,204.48 | Price 2.84 | Shares 8,185
Sale 27 Jun 2019
Value US$5,025.00 | Price 3.45 | Shares 1,458
Sale 25 Jun 2019
Value US$4,688.69 | Price 3.40 | Shares 1,380
Sale 29 Aug 2018
Value US$13,520.67 | Price 0.45 | Shares 29,999
Sale 28 Aug 2018
Value US$13,707.00 | Price 0.46 | Shares 30,000
Sale 28 Aug 2018
Value US$8,890.00 | Price 0.44 | Shares 20,000
Sale 27 Aug 2018
Value US$9,070.00 | Price 0.45 | Shares 20,000
Buy 27 Apr 2018
Value US$0.00 | Price 0.00 | Shares 282,350
Buy 27 Apr 2018
Value US$0.00 | Price 0.00 | Shares 58,900
Buy 27 Apr 2018
Value US$5,031,249.88 | Price 0.43 | Shares 11,838,235
Buy 27 Apr 2018
Value US$4,312,499.65 | Price 0.43 | Shares 10,147,058
Buy 27 Apr 2018
Value US$0.00 | Price 0.00 | Shares 2,211,765
Buy 27 Apr 2018
Value US$0.00 | Price 0.00 | Shares 47,100
Buy 8 Feb 2018
Value US$0.00 | Price 0.00 | Shares 50,000
Buy 8 Feb 2018
Value US$207,120.00 | Price 1.04 | Shares 200,000
Buy 8 Feb 2018
Value US$1,111,000.00 | Price 1.01 | Shares 1,100,000
Buy 26 Apr 2017
Value US$8,001.00 | Price 2.10 | Shares 3,810
Buy 26 Apr 2017
Value US$25,002.60 | Price 2.10 | Shares 11,906
Buy 26 Apr 2017
Value US$50,001.00 | Price 2.10 | Shares 23,810
Buy 26 Apr 2017
Value US$250,000.80 | Price 2.10 | Shares 119,048
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-28 2026-04-16 B Purchase
2.6
ORBIMED ADVISORS LLC
Large shareholder
69,557 +3.4%
439.47
US$1,495,250 		69,557 +3.4% 439.47 US$1,495,250
2024-03-14 2024-03-14 PrS Proposed sale
3.8
MARK GUERIN

Officer

Officer
54,868
89.65
US$724,304 		54,868 89.65 US$724,304
2024-03-14 2024-03-14 PrS Proposed sale
3.6
STEVEN M FRUCHTMAN

Officer; Director

Executive Director
24,815
489.34
US$1,318,311 		24,815 489.34 US$1,318,311
2024-02-08 2024-02-08 PrS Proposed sale
3.6
STEVEN M FRUCHTMAN

Officer; Director

Executive Director
9,212
0.67
US$6,173 		9,212 0.67 US$6,173
2022-01-31 2022-01-28 PP Planned purchase
3.9
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
1,500 +6.5%
1.67
US$2,505 		1,500 +6.5% 1.67 US$2,505
2022-01-24 2022-01-21 PP Planned purchase
3.9
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
1,500 +7.0%
2.02
US$3,030 		1,500 +7.0% 2.02 US$3,030
2022-01-18 2022-01-14 PP Planned purchase
3.9
OLER ABRAHAM N.

SVP CORP DEV & GEN COUNSEL

Officer
1,500 +7.5%
2.20
US$3,300 		1,500 +7.5% 2.20 US$3,300
2022-01-10 2022-01-07 PP Planned purchase
3.9
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
1,500 +8.1%
2.39
US$3,585 		1,500 +8.1% 2.39 US$3,585
2021-11-23 2021-11-19 B Purchase
3.9
OLER ABRAHAM N.

SVP CORP DEV & GEN COUNSEL

Officer
1,000 +5.7%
3.16
US$3,160 		1,000 +5.7% 3.16 US$3,160
2021-09-29 2021-09-28 B Purchase
3.9
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
2,381 +23.5%
4.20
US$10,000 		2,381 +23.5% 4.20 US$10,000
2021-09-29 2021-09-28 B Purchase
Gelder Mark S. MD

Chief Medical Officer

Officer
2,381 +inf%
4.20
US$10,000 		2,381 +inf% 4.20 US$10,000
2021-09-28 2021-09-28 B Purchase
3.8
MARINO JAMES J
Non-Executive Director
5,952 +38.7%
4.20
US$24,998 		5,952 +38.7% 4.20 US$24,998
2021-09-28 2021-09-28 B Purchase
3.6
Fruchtman Steven M

President, Chief Executive Off

Executive Director
2,381 +15.1%
4.20
US$10,000 		2,381 +15.1% 4.20 US$10,000
2021-02-17 2021-02-16 B Purchase
3.8
MARINO JAMES J
Non-Executive Director
25,000 +12.2%
1.00
US$25,000 		25,000 +12.2% 1.00 US$25,000
2021-02-17 2021-02-16 B Purchase
3.8
Guerin Mark Patrick

Chief Financial Officer

Officer
15,000 +11.5%
1.00
US$15,000 		15,000 +11.5% 1.00 US$15,000
2021-02-17 2021-02-16 B Purchase
3.6
Fruchtman Steven M

President, Chief Executive Off

Executive Director
20,000 +9.2%
1.00
US$20,000 		20,000 +9.2% 1.00 US$20,000
2021-02-17 2021-02-16 B Purchase
3.9
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
12,000 +8.6%
1.00
US$12,000 		12,000 +8.6% 1.00 US$12,000
2021-02-17 2021-02-16 B Purchase
3.4
Shoemaker Mary Teresa
Non-Executive Director
13,000 +34.5%
1.00
US$13,000 		13,000 +34.5% 1.00 US$13,000
2020-12-14 2020-12-11 B Purchase
3.9
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
30,000 +27.3%
0.32
US$9,600 		30,000 +27.3% 0.32 US$9,600
2020-11-30 2020-11-27 B Purchase
3.8
Guerin Mark Patrick

Chief Financial Officer

Officer
4,614 +3.7%
0.26
US$1,200 		4,614 +3.7% 0.26 US$1,200
2020-11-30 2020-11-25 B Purchase
3.4
Shoemaker Mary Teresa
Non-Executive Director
37,735 +inf%
0.27
US$10,000 		37,735 +inf% 0.27 US$10,000
2020-11-30 2020-11-25 B Purchase
3.8
Guerin Mark Patrick

Chief Financial Officer

Officer
16,755 +15.4%
0.26
US$4,356 		16,755 +15.4% 0.26 US$4,356
2020-11-30 2020-11-25 B Purchase
3.9
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
20,000 +22.2%
0.26
US$5,120 		20,000 +22.2% 0.26 US$5,120
2020-11-30 2020-11-25 B Purchase
3.6
Fruchtman Steven M

President, Chief Executive Off

Executive Director
40,000 +22.7%
0.26
US$10,360 		40,000 +22.7% 0.26 US$10,360
2020-11-27 2020-11-24 B Purchase
3.8
MARINO JAMES J
Non-Executive Director
38,774 +23.2%
0.26
US$10,004 		38,774 +23.2% 0.26 US$10,004
2020-08-31 2020-08-27 S Sale
3.9
Hoffman Michael B
Non-Executive Director
1,876 -100.0%
0.27
US$510 		1,876 -100.0% 0.27 US$510
2020-08-31 2020-08-27 S Sale
1.4
Reddy E Premkumar
Non-Executive Director
527,863 -96.9%
0.27
US$143,948 		527,863 -96.9% 0.27 US$143,948
2020-08-31 2020-08-27 S Sale
3.9
Hoffman Michael B
Non-Executive Director
182,492 -89.3%
0.27
US$49,620 		182,492 -89.3% 0.27 US$49,620
2020-05-21 2020-05-19 B Purchase
2.5
GROOPMAN JEROME
Non-Executive Director
10,000 +1000000.0%
0.36
US$3,626 		10,000 +1000000.0% 0.36 US$3,626
2020-05-20 2020-05-19 B Purchase
3.6
Fruchtman Steven M

President, Chief Executive Off

Executive Director
26,800 +17.9%
0.37
US$9,857 		26,800 +17.9% 0.37 US$9,857
2020-05-20 2020-05-19 B Purchase
3.8
Guerin Mark Patrick

Chief Financial Officer

Officer
21,000 +23.9%
0.36
US$7,560 		21,000 +23.9% 0.36 US$7,560
2020-05-20 2020-05-19 B Purchase
3.9
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
15,000 +20.0%
0.37
US$5,550 		15,000 +20.0% 0.37 US$5,550
2019-11-27 2019-11-25 B Purchase
MEHTA VIREN
250,000 +29171.5%
0.20
US$50,000 		250,000 +29171.5% 0.20 US$50,000
2019-11-26 2019-11-25 B Purchase OLER ABRAHAM N.

VP Corp Dev & Gen Counsel

Officer
75,000 +inf%
0.20
US$15,000 		75,000 +inf% 0.20 US$15,000
2019-11-26 2019-11-25 B Purchase Guerin Mark Patrick

Chief Financial Officer

Officer
87,500 +25436.0%
0.20
US$17,500 		87,500 +25436.0% 0.20 US$17,500
2019-11-26 2019-11-25 B Purchase MARINO JAMES J Non-Executive Director
150,000 +885.4%
0.20
US$30,000 		150,000 +885.4% 0.20 US$30,000
2019-11-26 2019-11-25 B Purchase Fruchtman Steven M

President, Chief Executive Off

Executive Director
149,000 +34976.5%
0.20
US$29,800 		149,000 +34976.5% 0.20 US$29,800
2019-11-26 2019-11-25 B Purchase Reddy E Premkumar Non-Executive Director
500,000 +1122.4%
0.20
US$100,000 		500,000 +1122.4% 0.20 US$100,000
2019-09-26 2019-09-25 B Purchase
3.8
MARINO JAMES J
7,260 +75.0%
1.60
US$11,616 		7,260 +75.0% 1.60 US$11,616
2019-09-26 2019-09-24 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
16,700 -2.6%
1.19
US$19,873 		16,700 -2.6% 1.19 US$19,873
2019-09-25 2019-09-23 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-09-25 2019-09-23 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
10,249 -1.2%
1.27
US$13,016 		10,249 -1.2% 1.27 US$13,016
2019-09-24 2019-09-23 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
37,242 -5.6%
1.23
US$45,968 		37,242 -5.6% 1.23 US$45,968
2019-09-24 2019-09-20 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
75,119 -10.1%
1.62
US$121,430 		75,119 -10.1% 1.62 US$121,430
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
1,533 -0.3%
2.20
US$3,376 		1,533 -0.3% 2.20 US$3,376
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
120,000 -20.6%
1.82
US$218,184 		120,000 -20.6% 1.82 US$218,184
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
173,332 -23.0%
2.18
US$377,448 		173,332 -23.0% 2.18 US$377,448
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
93,286 -11.0%
1.86
US$173,139 		93,286 -11.0% 1.86 US$173,139
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
118,726 -12.3%
2.18
US$258,538 		118,726 -12.3% 2.18 US$258,538
2019-09-20 2019-09-18 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
49,995 -6.3%
2.10
US$105,014 		49,995 -6.3% 2.10 US$105,014
2019-09-13 2019-09-11 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
1,247 -0.2%
2.75
US$3,432 		1,247 -0.2% 2.75 US$3,432
2019-09-11 2019-09-09 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
400 -0.1%
2.77
US$1,106 		400 -0.1% 2.77 US$1,106
2019-09-09 2019-09-06 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
5,015 -0.6%
2.78
US$13,954 		5,015 -0.6% 2.78 US$13,954
2019-09-09 2019-09-05 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
400 -0.0%
2.75
US$1,100 		400 -0.0% 2.75 US$1,100
2019-07-11 2019-07-10 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
2,742 -0.3%
2.81
US$7,697 		2,742 -0.3% 2.81 US$7,697
2019-07-11 2019-07-09 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
8,185 -1.0%
2.84
US$23,204 		8,185 -1.0% 2.84 US$23,204
2019-07-01 2019-06-27 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
1,458 -0.2%
3.45
US$5,025 		1,458 -0.2% 3.45 US$5,025
2019-06-27 2019-06-25 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
1,380 -0.2%
3.40
US$4,689 		1,380 -0.2% 3.40 US$4,689
2018-08-29 2018-08-29 S Sale Hoffman Michael B Non-Executive Director
29,999 -0.5%
0.45
US$13,521 		29,999 -0.5% 0.45 US$13,521
2018-08-29 2018-08-28 S Sale Hoffman Michael B Non-Executive Director
30,000 -0.5%
0.46
US$13,707 		30,000 -0.5% 0.46 US$13,707
2018-08-29 2018-08-28 S Sale Hoffman Michael B Non-Executive Director
20,000 -0.3%
0.44
US$8,890 		20,000 -0.3% 0.44 US$8,890
2018-08-29 2018-08-27 S Sale Hoffman Michael B Non-Executive Director
20,000 -0.3%
0.45
US$9,070 		20,000 -0.3% 0.45 US$9,070
2018-05-01 2018-04-27 B Purchase Reddy E Premkumar Non-Executive Director
282,350
0.00
US$0 		282,350 0.00 US$0
2018-05-01 2018-04-27 B Purchase MARINO JAMES J Non-Executive Director
58,900
0.00
US$0 		58,900 0.00 US$0
2018-05-01 2018-04-27 B Purchase 683 Capital Management, LLC Large shareholder
11,838,235 +444.2%
0.43
US$5,031,250 		11,838,235 +444.2% 0.43 US$5,031,250
2018-05-01 2018-04-27 B Purchase TYNDALL CAPITAL PARTNERS L P Large shareholder
10,147,058 +483.9%
0.43
US$4,312,500 		10,147,058 +483.9% 0.43 US$4,312,500
2018-05-01 2018-04-27 B Purchase Hoffman Michael B Non-Executive Director
2,211,765
0.00
US$0 		2,211,765 0.00 US$0
2018-05-01 2018-04-27 B Purchase STOVER JACK E Non-Executive Director
47,100
0.00
US$0 		47,100 0.00 US$0
2018-02-12 2018-02-08 B Purchase MARINO JAMES J Non-Executive Director
50,000
0.00
US$0 		50,000 0.00 US$0
2018-02-12 2018-02-08 B Purchase 683 Capital Management, LLC Large shareholder
200,000 +8.1%
1.04
US$207,120 		200,000 +8.1% 1.04 US$207,120
2018-02-12 2018-02-08 B Purchase TYNDALL CAPITAL PARTNERS L P Large shareholder
1,100,000 +110.3%
1.01
US$1,111,000 		1,100,000 +110.3% 1.01 US$1,111,000
2017-04-28 2017-04-26 B Purchase Bienen Henry S
3,810 +42.7%
2.10
US$8,001 		3,810 +42.7% 2.10 US$8,001
2017-04-28 2017-04-26 B Purchase MARINO JAMES J
11,906 +48.8%
2.10
US$25,003 		11,906 +48.8% 2.10 US$25,003
2017-04-28 2017-04-26 B Purchase Kumar Ramesh

President and CEO

Executive Director
23,810 +30.4%
2.10
US$50,001 		23,810 +30.4% 2.10 US$50,001
2017-04-28 2017-04-26 B Purchase Reddy E Premkumar
119,048 +44.6%
2.10
US$250,001 		119,048 +44.6% 2.10 US$250,001
Explore more

More insider trading research around Traws Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America